L L N Husemoen1, T Skaaby1, B H Thuesen1, N Grarup2, C H Sandholt2, T Hansen2,3, O Pedersen2, A Linneberg1,4,5. 1. Research Centre for Prevention and Health, The Capital Region of Denmark, Glostrup University Hospital, Glostrup, Denmark. 2. The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. 3. University of Southern Denmark, Odense, Denmark. 4. University of Copenhagen, Copenhagen, Denmark. 5. Department of Clinical Experimental Research, Rigshospitalet, Glostrup, Copenhagen, Denmark.
Abstract
BACKGROUND/ OBJECTIVES: The aim was to examine the association of genetic risk scores (GRSs) of vitamin B12 and folate-associated variants with blood pressure and lipids. SUBJECTS/ METHODS: The study included 12 532 adults from three population-based studies (Inter99, Health2006 and Dan-MONICA10) conducted in Denmark. GRSs were calculated by summarising the number of vitamin B12 and folate increasing alleles. Weighted GRSs were calculated as the sum of weights for each allele corresponding to genetic effects sizes. RESULTS: GRSs for serum vitamin B12 and folate were associated with serum vitamin B12 and folate, respectively. The β coefficients (95% confidence interval (CI), P-value) for regression of log-transformed serum B12/folate on the weighted GRSs were 0.57 (0.54, 0.61), P<0.001 and 0.85 (0.70, 1.01), P<0.01. No associations were observed between the vitamin B12 GRSs and any of the blood pressure and lipid-related outcomes in the combined analyses. Increasing number of folate increasing alleles was associated with increased high-density lipoprotein (HDL) cholesterol concentrations (β coefficient (95% CI, P-value) for regression of log-transformed HDL on the weighted GRSs, 0.081 (0.015, 0.148), P=0.017), but not with blood pressure, triglyceride, and low-density lipoprotein and total cholesterol levels. CONCLUSIONS: GRSs were not associated with blood pressure and lipid levels, except for an association between the GRS for folate and HDL cholesterol. Further studies are needed to determine whether a causal association between folate and HDL cholesterol exists.
BACKGROUND/ OBJECTIVES: The aim was to examine the association of genetic risk scores (GRSs) of vitamin B12 and folate-associated variants with blood pressure and lipids. SUBJECTS/ METHODS: The study included 12 532 adults from three population-based studies (Inter99, Health2006 and Dan-MONICA10) conducted in Denmark. GRSs were calculated by summarising the number of vitamin B12 and folate increasing alleles. Weighted GRSs were calculated as the sum of weights for each allele corresponding to genetic effects sizes. RESULTS: GRSs for serum vitamin B12 and folate were associated with serum vitamin B12 and folate, respectively. The β coefficients (95% confidence interval (CI), P-value) for regression of log-transformed serum B12/folate on the weighted GRSs were 0.57 (0.54, 0.61), P<0.001 and 0.85 (0.70, 1.01), P<0.01. No associations were observed between the vitamin B12 GRSs and any of the blood pressure and lipid-related outcomes in the combined analyses. Increasing number of folate increasing alleles was associated with increased high-density lipoprotein (HDL) cholesterol concentrations (β coefficient (95% CI, P-value) for regression of log-transformed HDL on the weighted GRSs, 0.081 (0.015, 0.148), P=0.017), but not with blood pressure, triglyceride, and low-density lipoprotein and total cholesterol levels. CONCLUSIONS: GRSs were not associated with blood pressure and lipid levels, except for an association between the GRS for folate and HDL cholesterol. Further studies are needed to determine whether a causal association between folate and HDL cholesterol exists.
Authors: Mariska Klerk; Petra Verhoef; Robert Clarke; Henk J Blom; Frans J Kok; Evert G Schouten Journal: JAMA Date: 2002 Oct 23-30 Impact factor: 56.272
Authors: Lise Lotte N Husemoen; Troels F Thomsen; Mogens Fenger; Henrik L Jørgensen; Torben Jørgensen Journal: Genet Epidemiol Date: 2003-05 Impact factor: 2.135
Authors: William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub Journal: N Engl J Med Date: 2011-11-15 Impact factor: 91.245
Authors: Sari Voutilainen; Jyrki K Virtanen; Tiina H Rissanen; Georg Alfthan; Jari Laukkanen; Kristiina Nyyssönen; Jaakko Mursu; Veli-Pekka Valkonen; Tomi-Pekka Tuomainen; George A Kaplan; Jukka T Salonen Journal: Am J Clin Nutr Date: 2004-08 Impact factor: 7.045
Authors: James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer Journal: JAMA Date: 2004-02-04 Impact factor: 56.272
Authors: L T Møllehave; T Skaaby; K S Simonsen; B H Thuesen; E L Mortensen; C H Sandholt; O Pedersen; N Grarup; T Hansen; A Linneberg Journal: Eur J Clin Nutr Date: 2017-06-28 Impact factor: 4.016
Authors: Nathan V Matusheski; Aoife Caffrey; Lars Christensen; Simon Mezgec; Shelini Surendran; Mads F Hjorth; Helene McNulty; Kristina Pentieva; Henrik M Roager; Barbara Koroušić Seljak; Karani Santhanakrishnan Vimaleswaran; Marcus Remmers; Szabolcs Péter Journal: Br J Nutr Date: 2021-01-29 Impact factor: 3.718